The use of pilocarpine hydrochloride to prevent xerostomia in a child treated with high dose radiotherapy for nasopharynx carcinoma

Oral Oncology

Volumn 34, Issue 5, 1998, Pages 381-382

  Deutsch, M ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Childhood cancer; Nasopharynx carcinoma; Parotid gland irradiation; Pilocarpine; Xerostomia

Indexed keywords

PILOCARPINE;

ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CERVICAL LYMPH NODE; CHILD; HUMAN; LYMPH NODE METASTASIS; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME; XEROSTOMIA;

CHILD; HUMANS; MALE; MIOTICS; NASOPHARYNGEAL NEOPLASMS; PILOCARPINE; RADIOTHERAPY; XEROSTOMIA;

EID: 0032167458     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00016-5     Document Type: Article

References (5)

1. Johnson JT, Ferretti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. New England Journal of Medicine. 329:1993;390-395.
2. LeVeque FG, Montgomery M, Potter D, et al. A multicenter, randomized, doubleblind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. Journal of Clinical Oncology. 11:1993;1124-1131.
3. Davies AN, Singer J. A comparison of artificial saliva and pilocarpine in radiation-induced xerostomia. J Laryngol Otol. 108:1994;663-665.
4. Valdez IH, Wolff A, Atkinson JC, Macynski AA, Fox PC. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction. Cancer. 71:1993;1848-1851.
5. Zimmerman RP, Mark RJ, Tran LM, Juillard GF. Concomitant pilocarpine during head and neck irradiation is associated with decreased postradiation xerostomia. International Journal of Radiation, Oncology, Biology and Physics. 37:1997;571-575.